Segmed Appoints David Gascoigne as CEO Amid Leadership Changes

Segmed has appointed David Gascoigne as its new CEO, transitioning co-founder Dr. Martin Willemink to Chief Scientific Officer and adding Dr. Yin Ho to its Board of Directors.

Segmed has appointed David Gascoigne as its new Chief Executive Officer, announced in a press release. This leadership transition also sees co-founder Dr. Martin Willemink moving to the role of Chief Scientific Officer, while Dr. Yin Ho joins the Board of Directors.

David Gascoigne brings over 30 years of experience in healthcare, life sciences, and AI, having previously served as CEO of Almaden Genomics. His appointment comes as Segmed aims to expand its reach and innovation in medical imaging and AI-driven healthcare solutions.

Dr. Martin Willemink, who has led Segmed through significant growth and funding rounds, will now focus on advancing the company's scientific vision and market presence. Meanwhile, Dr. Yin Ho, with her extensive background in healthcare IT and clinical research, will contribute strategic insights as an Independent Director.

We hope you enjoyed this article.

Consider subscribing to one of several newsletters we publish. For example, in the Daily AI Brief you can read the most up to date AI news round-up 6 days per week.

Also, consider following us on social media:

Subscribe to Daily AI Brief

Daily report covering major AI developments and industry news, with both top stories and complete market updates

Sponsored

AI Token Webinar

Whitepaper

Stanford HAI’s 2025 AI Index Reveals Record Growth in AI Capabilities, Investment, and Regulation

The 2025 AI Index by Stanford HAI provides a comprehensive overview of the global state of artificial intelligence, highlighting significant advancements in AI capabilities, investment, and regulation. The report details improvements in AI performance, increased adoption in various sectors, and the growing global optimism towards AI, despite ongoing challenges in reasoning and trust. It serves as a critical resource for policymakers, researchers, and industry leaders to understand AI's rapid evolution and its implications.

Read more